MedTrace Logo

Implementing Patients´ Competence in Oral Breast Cancer Therapy

NCT04030728 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 212

Last updated 2020-02-05

No results posted yet for this study

Summary

The aim of the IMPACT - Implementing Patients' competence in oral breast cancer therapy - study is to evaluate the effectiveness of a standardized patient education and coaching and optional eMBSR for therapy management provided by specially trained oncology nurses regarding persistence rate, side effects management and unplanned therapy interruptions in outpatient oncology care for patients under Abemaciclib treatment.

Conditions

Sponsors & Collaborators

  • Eli Lilly and Company

    collaborator INDUSTRY

  • Institut fuer Frauengesundheit

    collaborator OTHER

  • Onco Medical Consult GmbH

    lead INDUSTRY

Principal Investigators

  • Hans Tesch, Prof. Dr. med. · Onkologie Bethanien Frankfurt

  • Manfred Welslau, Dr. med. · Onkologie Aschaffenburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2021-09-30
Completion
2021-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04030728 on ClinicalTrials.gov